Reverse transcriptase inhibition potentiates target therapy in BRAF-mutant melanomas: effects on cell proliferation, apoptosis, DNA-damage, ROS induction and mitochondrial membrane depolarization

ABSTRACT: Target therapies based on BRAF and MEK inhibitors (MAPKi) have changed the therapeutic landscape for metastatic melanoma patients bearing mutations in the BRAF kinase. However, the emergence of drug resistance imposes the necessity to conceive novel therapeutic strategies capable to achiev...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cell Commun Signal
Main Authors: Fattore, Luigi, Malpicci, Debora, Milite, Ciro, Castellano, Sabrina, Sbardella, Gianluca, Botti, Gerardo, Ascierto, Paolo A., Mancini, Rita, Ciliberto, Gennaro
格式: Artigo
語言:Inglês
出版: BioMed Central 2020
主題:
Short Report
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7493390/
https://ncbi.nlm.nih.gov/pubmed/32933538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-020-00633-7
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍